News ALS Association Invests $3M in Platform Trial to Accelerate Development of Treatments

News Neuropore’s Potential ALS Oral Treatment Found to be Safe and Well-Tolerated in Healthy Volunteers, Phase 1 Trial Shows

Columns, Joyful Sorrow - a Column by Kristin Neva I’m Channeling My Grief About ALS into Action and Advocacy

News Neos Completes Dosing in Phase 1 Trial of Anti-Drooling Treatment NT0502 in Healthy Volunteers

News Alexion to Initiate Phase 3 Trial of Ultomiris for Familiar, Sporadic ALS Patients

Columns, Living Well with ALS - a column by Dagmar Munn A New Paradigm for the Future of ALS

News ALS Research Ambassador Collaboration Enabled More Patient-centered Design of REFINE-ALS Trial

News AstroRx Increases Ability to Perform Daily Functions in ALS Patients, Trial Results Show

News Kadimastem Finishes Treating Second Group of ALS Patients with AstroRx in Phase 1/2a Trial

Columns, Joyful Sorrow - a Column by Kristin Neva Learning the Rules for the Medicare Guessing Game

News Mitochondrial ‘Suicide’ May Signal Start of Neurodegeneration in ALS, Mouse Study Suggests

News Insurance Data May Predict ALS, Research Shows

Columns, Living Well with ALS - a column by Dagmar Munn Join Our Virtual Friendly Neighborhood, the ALS News Today Forums

News END ALS Association Founder Lights Up Room With Holiday Spirit to Raise Disease Awareness

News Top Scientist and Tattooed Patient Jointly Spur ALS Research in Sweden

News BrainStorm Cell Therapeutics Wins 2020 ‘Buzz of BIO’ Award for Investigational Cellular Treatment

Columns, Joyful Sorrow - a Column by Kristin Neva Ordinary Outings Are Arduous with ALS

News Top 10 ALS Stories of 2019

News Answer ALS Project to Better Understand and Treat Disease Moves into New Phase

Columns, Joyful Sorrow - a Column by Kristin Neva Even Trees Die with No Known Cause or Cure

News Reldesemtiv Earns FDA’s Orphan Drug Designation for ALS Treatment

Columns, Notes From the ALS Front - a Column by Rick Jobus The Art of Declaring War on ALS

News AMX0035 Significantly Slows Disease Progression in ALS, Phase 2 Study Shows

News Soleo and Mitsubishi Tanabe Enter Data-sharing Agreement for Radicava

News FDA Approves Dosing Tiglutik Via Feeding Tube for ALS Patients

News Ibudilast Most Effective in People with Short History of ALS, Analysis Suggests

Columns, Joyful Sorrow - a Column by Kristin Neva In Defense of Delight in the Midst of Suffering

News Orion Presents Data on How Levosimendan Works in ALS and Disease Biomarkers

News New ALS Investment Fund Partnership Seeks to Raise $100M to Accelerate Research

Columns, Living Well with ALS - a column by Dagmar Munn What (Not) to Say to a Friend Who Has ALS

News Gene Therapy Takes Center Stage at 2019 NORD Summit

News Reldesemtiv Effects Maintained When Used on Top of Rilutek or Radicava, New Trial Analysis Shows

News CurePSP Grant to FTD Disorders Registry Intended to Educate, Raise Awareness About Neurodegenerative Disorders

Columns, Joyful Sorrow - a Column by Kristin Neva Grief Is a Wolf that Demands Attention

News ‘Jumping Genes’ Identified as Possible Cause of ALS, Linked to TDP-43 Protein Accumulation

News HHS Secretary Alex Azar Touts White House Efforts to Cure Rare Diseases

News Washington State Beats University of Washington in ALS Fundraising Challenge for Team Gleason

News Anti-Inflammatory Delays ALS Symptoms and Progression in Mouse Model, Study Reports

Columns, Notes From the ALS Front - a Column by Rick Jobus I’m Thankful for the People Who Enrich My Life

News 1st ALS Patient Enters Phase 3 Study of Oral Edaravone in Slowing Disability

Columns, Living Well with ALS - a column by Dagmar Munn Sharing My ALS Clinic Chuckles

News Exservan, Riluzole in Dissolving Oral Film Form, Approved by FDA

News Phase 2 Trial Data on NurOwn Therapy, Supporting Safety And Early Efficacy, Published

News $106M Weill Family Foundation Gift Opens Research Network to Advance Neuroscience

Columns, Joyful Sorrow - a Column by Kristin Neva We’re Figuring Out Healthcare on Our Own in Rural America

News ALS Candidate AT-1501 Advances to Phase 2 Studies, Anelixis Therapeutics Announces

Columns, Notes From the ALS Front - a Column by Rick Jobus Anger (Mis)Management: Seeking an Object of Blame for ALS

News Kadimastem Seeks to Amend Protocol of its Trial Testing ALS Stem Cell Therapy AstroRx

Columns, Living Well with ALS - a column by Dagmar Munn The 4 Ms: My Formula for Daily Living

News ALS Association Golden West Chapter Honors Mitsubishi Tanabe for Work into Treatments

News ALS Prevalent Among Young Veterans Deployed in Post-9/11 U.S. Wars, Study Shows

News Aquestive Licenses ALS Therapy Riluzole Oral Film to Zambon in the European Union

Columns, Joyful Sorrow - a Column by Kristin Neva Calculating Risks While Balancing Family Life and ALS

News Blocking SARM1 Prevents Neuronal Degeneration in Mice and Cell Models, Study Shows

amyotrophic lateral sclerosis (ALS), News Rare Disease Film Festival Highlights Patient and Researcher Unity

Columns, Notes From the ALS Front - a Column by Rick Jobus Black Tie Optional: Dressing for Success with ALS

News MRI-guided Focused Ultrasounds Can Safely Open Brain-Blood Barrier in ALS Patients, Trial Shows

Columns, Living Well with ALS - a column by Dagmar Munn My Tricks for Adding Movement to My Day

News Aural, TGen Collaborate on Trial Assessing Effects of Acupuncture on Recently Diagnosed ALS Patients

News Radicava Now Commercially Available in Canada, MTP-CA Announces

News With $300K Grant, ALS Never Surrender Foundation Launches Mobile App to Track Disease Progression

Columns, Joyful Sorrow - a Column by Kristin Neva Wartime Living Tests Marriages

News Exercise Helps to Slow Motor Neuron Loss in ALS, Study Suggests, But Type of Activity May Be Key

Columns, Notes From the ALS Front - a Column by Rick Jobus A Night of Heroes: I Was Humbled to Speak at an MDA Fundraiser

Columns, Living Well with ALS - a column by Dagmar Munn The Power of My ALS Role Models

News Canada Approves New Patent Covering Ibudilast’s Use for ALS Treatment

News AcuraStem Advancing Second Stage of Small Molecule Development for ALS Treatment

News Phase 3 Trial of NurOwn, Cell Therapy for ALS, Gets Thumbs Up in Safety Review by Independent Board

Columns, Joyful Sorrow - a Column by Kristin Neva Imagining Our Lives Without ALS

News Canadian Health Professionals Recommend Stretching More, But Science Remains Shaky, Survey Finds

News First ALS Patient Enters US Study of Radicava’s Impact on Disease Biomarkers

Columns, Living Well with ALS - a column by Dagmar Munn I’ll Have What She’s Having: ‘ALS Reversals’ Share Good Advice

News ProMIS Neurosciences Develops Antibodies Targeting TDP-43 Aggregates, an ALS Hallmark

News New Assistive Technology Kit to Aid Drake University’s Caregiver Learning Labs

News Mouse Study Uncovers Role of FUS Protein in ALS Neuromuscular Junction Defects

Columns, Joyful Sorrow - a Column by Kristin Neva We’ve Learned to Compartmentalize Family Life While Living with ALS

News Phase 2 CENTAUR Trial for AMX0035 Included Most Severe ALS Patients to Maximize Statistical Power, Experts Explain in Webinar

News Protein Related to ALS Onset Used to Develop New Method of Antibody Validation for Use in Research

News Common Mutation in IL6R Gene May Mark More Severe and Faster Progressing ALS, Study Says

News New University of Washington Center to Produce Stem Cells for Research on Muscle Disorders Such as ALS

News $5M in Grants to Support Work into Treatments, Biomarkers for ALS and Frontotemporal Degeneration

Columns, Joyful Sorrow - a Column by Kristin Neva Just Breathe: Dealing with Chronic Stress

News First ALS Patient Enrolled in Phase 1 Trial of AP-101, AL-S Pharma AG Announces

Columns, Notes From the ALS Front - a Column by Rick Jobus Adding MDA’s Vast Resources to My ALS Arsenal and Giving Back

News First ALS Patient Enrolled in Phase 2/3 Trial of CuATSM, CMD Announces

News Mexiletine Reduces Frequency, Severity of Muscle Cramps in ALS, Trial Shows

News Phase 3 Trial of NurOwn Cell Therapy Fully Enrolls 200 Patients, BrainStorm Announces

News Harvard Researcher Wins 2019 AANEM Scientific Impact Award for Study of Fingolimod in ALS

Columns, Joyful Sorrow - a Column by Kristin Neva Coming Unstuck and Reaching Beyond Ourselves

News Potential Treatment of Mitochondria Seen to Delay Neurologic Symptoms in ALS Mouse Model

Columns, Notes From the ALS Front - a Column by Rick Jobus Envisioning a Bright Future for Our Survivors

News CENTAUR Phase 2 Trial of AMX0035, Potential ALS Treatment, Finishes Collecting Data

Columns, Living Well with ALS - a column by Dagmar Munn Celebrating My Public and Personal Milestones

News Reldesemtiv Slows Decline in Muscle Control Needed for Speech, Phase 2 Trial Analysis Finds

News Reldesemtiv May Reduce Functional Decline in Fast Progressing ALS, New Analysis Suggests

News U.S. Department of Defense Earmarks $758,121 to Develop RASRx1902 as Potential ALS Therapy

Columns, Joyful Sorrow - a Column by Kristin Neva Navigating ALS with Children in Tow

News CZI Awards I AM ALS $453K Grant to Share Tools That Will Speed Investigations Into ALS, Other Rare Diseases

Columns, Notes From the ALS Front - a Column by Rick Jobus Could Thinking Outside the Box Lead to a Cure for ALS?

News Animal Study Examines Familial ALS Mutations, Disruptions in the ANXA11 Gene